ID Source | ID |
---|---|
PubMed CID | 17522 |
CHEMBL ID | 2271089 |
CHEBI ID | 38621 |
SCHEMBL ID | 83422 |
MeSH ID | M0057733 |
Synonym |
---|
cyanophos |
phosphorothioic acid, o-(4-cyanophenyl) o,o-dimethyl ester |
o-4-cyanophenyl o o-dimethyl phosphorothioate |
ciafos |
o,o-dimethyl o-(4-cyanophenyl) thionophosphate |
CHEBI:38621 , |
o-p-cyanophenyl o,o-dimethyl phosphorothioate |
o,o-dimethyl-o-p-cyanophenyl phosphorothioate |
2636-26-2 |
4-(dimethoxyphosphinothioyloxy)benzonitrile |
o-(4-cyanophenyl) o,o-dimethyl phosphorothioate |
o-(4-cyanophenyl) o,o-dimethyl thiophosphate |
oms 869 |
bayer 34727 |
phosphorothioic acid, o,o-dimethyl ester, o-ester with p-hydroxybenzonitrile |
cyanophos [bsi:iso] |
einecs 220-130-3 |
cyap |
oms 226 |
cyanox |
o,o-dimethyl-o-(4-cyano-phenyl)-monothiophosphat [german] |
o,o-dimethyl o-4-cyanophenyl thiophosphate |
bay 34727 |
o,o-dimethyl o-4-cyanophenyl phosphorothioate |
brn 2695901 |
o,o-dimethyl phosphorothioate o-ester with p-hydroxybenzonitrile |
may & baker s-4084 |
ent 25,675 |
epa pesticide chemical code 268200 |
cynock |
s 4084 |
ai3-25675 |
caswell no. 268a |
(o-p-cyanophenyl-o,o-dimethylphosphorothioate) |
hsdb 6427 |
sumitomo s 4084 |
o-4-cyanophenyl o,o-dimethyl phosphorothioate |
4-dimethoxyphosphinothioyloxybenzonitrile |
C18397 |
unii-2ab0z99oxp |
o,o-dimethyl-o-(4-cyano-phenyl)-monothiophosphat |
2ab0z99oxp , |
FT-0603169 |
AKOS015888321 |
SCHEMBL83422 |
S-4084 , |
CHEMBL2271089 |
phosphorothioic acid o-(4-cyanophenyl) o,o-dimethyl ester |
cyanophos [mi] |
cyanophos [iso] |
cyanophos [hsdb] |
bay-34727 |
phosphorothioic acid o,o-dimethyl ester, o-ester with p-hydroxybenzonitrile |
o,o-dimethyl-o-(4-cyano-phenyl)-monothiophosphate |
o,o-dimethyl o-(p-cyanophenyl) phosphorothioate |
o-(4-cyanophenyl) o,o-dimethyl thiophosphate # |
DTXSID0041806 |
cyanophos, pestanal(r), analytical standard |
J-016395 |
Q1147014 |
cyanophos 10 microg/ml in isooctane |
Excerpt | Relevance | Reference |
---|---|---|
" 14C-recoveries (expressed as % relative to the dosed 14C) in faeces and urine were 2-3 and 95-96% respectively for the low-dose and 13-14 and 86% respectively for the high-dose." | ( Metabolism of Cyanox in the rat. I. Absorption, disposition, excretion and biotransformation. Kaneko, H; Nakatsuka, I; Onogi, M; Saito, K; Shiba, K; Tomigahara, Y; Yamada, H, 1995) | 0.29 |
Role | Description |
---|---|
agrochemical | An agrochemical is a substance that is used in agriculture or horticulture. |
EC 3.1.1.7 (acetylcholinesterase) inhibitor | An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
organothiophosphate insecticide | |
organic thiophosphate | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.78) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |